The TCF7L2 Gene: Dietary Prevention of T2DM
The TCF7L2 Gene: Nutrigenomics and Dietary Prevention of Type 2 Diabetes
Sponsor: Allen Foundation Inc.
Terminated
COVID-19
A NA clinical study on Glucose, High Blood and Type2 Diabetes, this trial is terminated or withdrawn. The trial is conducted by Allen Foundation Inc. and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Oct 2024 — Present [monthly]
Terminated NA
Status: Unknown → Terminated
-
Sep 2024 — Oct 2024 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
May 2021 — May 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — May 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allen Foundation Inc.
- Tufts University
For direct contact, visit the study record on ClinicalTrials.gov .